B Munos

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi request reprint Can open-source R&D reinvigorate drug research?
    Bernard Munos
    Bernard Munos is at Eli Lilly and Co, Lilly Corporate Center, 1085, Indianapolis, Indiana 46285, USA
    Nat Rev Drug Discov 5:723-9. 2006
  2. doi request reprint A forensic analysis of drug targets from 2000 through 2012
    B Munos
    InnoThink Center for Research in Biomedical Innovation, Indianapolis, Indiana, USA
    Clin Pharmacol Ther 94:407-11. 2013
  3. doi request reprint Can open-source drug R&D repower pharmaceutical innovation?
    B Munos
    Corporate Strategy, Eli Lilly and Company, Indianapolis, Indiana, USA
    Clin Pharmacol Ther 87:534-6. 2010
  4. doi request reprint How to revive breakthrough innovation in the pharmaceutical industry
    Bernard H Munos
    InnoThink Center for Research in Biomedical Innovation, Indianapolis, IN 46228 1422, USA
    Sci Transl Med 3:89cm16. 2011

Detail Information

Publications4

  1. ncbi request reprint Can open-source R&D reinvigorate drug research?
    Bernard Munos
    Bernard Munos is at Eli Lilly and Co, Lilly Corporate Center, 1085, Indianapolis, Indiana 46285, USA
    Nat Rev Drug Discov 5:723-9. 2006
    ..Can open-source drug research and development, using principles pioneered by the highly successful open-source software movement, help revive the industry?..
  2. doi request reprint A forensic analysis of drug targets from 2000 through 2012
    B Munos
    InnoThink Center for Research in Biomedical Innovation, Indianapolis, Indiana, USA
    Clin Pharmacol Ther 94:407-11. 2013
    ..It examines their modes of action, highlights key trends, and discusses their implications for our ability to generate innovation...
  3. doi request reprint Can open-source drug R&D repower pharmaceutical innovation?
    B Munos
    Corporate Strategy, Eli Lilly and Company, Indianapolis, Indiana, USA
    Clin Pharmacol Ther 87:534-6. 2010
    ..Is open innovation the answer to the innovation crisis? This Commentary argues that although it may likely be part of the solution, significant cultural, scientific, and regulatory barriers can prevent it from delivering on its promise...
  4. doi request reprint How to revive breakthrough innovation in the pharmaceutical industry
    Bernard H Munos
    InnoThink Center for Research in Biomedical Innovation, Indianapolis, IN 46228 1422, USA
    Sci Transl Med 3:89cm16. 2011
    ....